Tubize-Fin
TUB · BR · Healthcare / Biotechnology
242.60EUR+0.60 (+0.25%)
Price History
Full chartMarket Stats
Previous Close242.00
Open242.00
Day Range241.60 – 244.40
52-Week Range168.10 – 249.56
Volume11.04K
Market Cap10.67B
P/E (TTM)111.53
Forward P/E30.96
EPS2.15
Dividend Yield0.45%
Beta0.32
50-Day Avg186.53
200-Day Avg206.88
About
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium. It focuses on the discovery and development of treatments for patients suffering from diseases affecting immune or central nervous system. The company was founded in 1928 and is based in Brussels, Belgium.
Company Details
- SectorHealthcare
- IndustryBiotechnology
- CEOMr. Eric Nys
- Employees0
- HeadquartersAllée de la Recherche 60, Brussels, Belgium, 1070, Belgium
- Websitehttps://www.financiere-tubize.be
Leadership
- Mr. Eric NysManaging Director
- Ms. Anne Sophie PijckeGeneral Manager
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Market Cap10.67B
Enterprise Value10.07B
Trailing P/E111.53
Forward P/E30.96
PEG Ratio1.24
Price / Sales1000000.00
Price / Book5.10
EPS2.15
Book Value44.62
Revenue (TTM)13.26K
Gross Profit (TTM)-3.03M
EBITDA-3.03M
Profit Margin0.00%
Operating Margin0.00%
Return on Equity5.02%
Return on Assets-0.10%
Shares Outstanding44.51M
Shares Float20.71M
Beta0.32
Dividend Yield0.45%
Dividend Rate1.08
Payout Ratio48.85%
Dividends
20261×
0.76May 7, 2026
20251×
0.73Apr 30, 2025
20241×
0.68Apr 30, 2024
20231×
0.60May 3, 2023
20221×
0.53May 3, 2022
20211×
0.48May 4, 2021
20201×
0.43May 6, 2020
20191×
0.39May 2, 2019
20181×
0.38May 2, 2018
20171×
0.36May 3, 2017
20161×
0.36May 5, 2016
20151×
0.36May 6, 2015
20141×
0.36May 2, 2014
20131×
0.36May 2, 2013
20121×
0.36Apr 27, 2012
20111×
0.36May 2, 2011
20101×
0.36May 3, 2010
20091×
0.36May 5, 2009
20081×
0.35Apr 29, 2008
20071×
0.35Apr 30, 2007
20061×
0.34Jun 16, 2006
20051×
0.66Jun 17, 2005
20041×
0.31Jun 11, 2004
20031×
0.28Jun 13, 2003
Stock Splits
- Jun 17, 20052:1
- Nov 26, 1999100:1